In Monday’s Wall Street session, Hims & Hers Health Inc (NYSE:HIMS) shares traded at $59.78, up 7.75% from the previous session.
HIMS stock price is now 32.52% away from the 50-day moving average and 83.25% away from the 200-day moving average. The market capitalization of the company currently stands at $13.38B.
With the price target enhanced from $61 to $65, Needham maintained Buy rating for Hims & Hers Health Inc (NYSE: HIMS). On April 29, 2025, TD Cowen Downgraded its previous ‘Buy’ rating to ‘Hold’ on the stock keeping its target price maintained at $30, while ‘Morgan Stanley’ rates the stock as ‘Equal-Weight’
In other news, Melissa Baird, Officer bought 33,333 shares of the company’s stock on Jun 16 ’25. The stock was bought for $1,992,647 at an average price of $59.78. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 16 ’25, Officer Dudum Andrew bought 47,534 shares of the business’s stock. A total of $2,685,348 was incurred on buying the stock at an average price of $56.49. A total of 10.38% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $13.47 and a high of $72.98. As of last week, the company has a debt-to-equity ratio of 0.12, a current ratio of 1.59, and a quick ratio of 1.32.
The net profit margin was 9.21% and return on equity was 36.79% for HIMS. The company reported revenue of $586.01 million for the quarter, compared to $278.17 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 110.67 percent.
